Sinha Smeeta, Eddington Helen, Kalra Philip A
Salford Royal Foundation Trust Hospital, Salford M6 8HD, UK.
J Ren Care. 2009 Mar;35 Suppl 1:51-6. doi: 10.1111/j.1755-6686.2009.00065.x.
Patients with chronic kidney disease have increased cardiovascular mortality from a combination of increased atherosclerotic disease, left ventricular hypertrophy and increased prevalence of vascular calcification (VC). Previously VC was thought to be a passive process which involved the deposition of calcium and phosphate into the vessel wall. However, recent studies have shown that VC is a highly regulated, cell-mediated process similar to bone formation, in that it is associated with expression of bone-related proteins, such as type I collagen and alkaline phosphatase. Animal and in vitro models of VC have shown that a multitude of factors including phosphate, matrix gla protein (MGP) and fetuin are involved in regulating VC. Certain factors induce calcification whereas others inhibit the process. Despite these insights, it is still not fully known how VC is regulated and a treatment for VC remains elusive. Ongoing research will hopefully elucidate these mechanisms and thereby produce targets for future therapeutic intervention. This review will highlight some of the scientific models of VC and how they have increased the understanding of this complex process.
慢性肾脏病患者由于动脉粥样硬化疾病增加、左心室肥厚以及血管钙化(VC)患病率上升,心血管死亡率升高。以前,VC被认为是一个被动过程,涉及钙和磷酸盐在血管壁的沉积。然而,最近的研究表明,VC是一个高度受调控的、细胞介导的过程,类似于骨形成,因为它与骨相关蛋白的表达有关,如I型胶原蛋白和碱性磷酸酶。VC的动物模型和体外模型表明,包括磷酸盐、基质γ-羧基谷氨酸蛋白(MGP)和胎球蛋白在内的多种因素参与调节VC。某些因素诱导钙化,而其他因素则抑制这一过程。尽管有这些见解,但VC如何被调控仍不完全清楚,且VC的治疗方法仍然难以捉摸。正在进行的研究有望阐明这些机制,从而为未来的治疗干预提供靶点。本综述将重点介绍一些VC的科学模型以及它们如何增进了对这一复杂过程的理解。